Acumen Pharmaceuticals, Inc. · NASDAQ:ABOS

Stalfort John A III received 35,500 Acumen Pharmaceuticals, Inc. shares as an award (Form 4)

Traded Jun 3, 2026 · Filed Jun 5, 2026

On Jun 3, 2026, Stalfort John A III (Director) received 35,500 Acumen Pharmaceuticals, Inc. shares as an award, leaving 220,624 shares. Filed Jun 5, 2026 (Form 4).

Awarded
35,500 shares
Holding after
220,624 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 3, 2026Common StockAward35,500220,624Direct

Source

View original at SEC

Related